Evidence based Cardiology was first published in 1998 to universal acclaim. Now, with the move towards more patient focused health care and at the same time increased emphasis on health economics, evidence-based practice is a more important force in health care delivery than ever. This new third edition, written by the world's leading cardiologists, provides graded evidence-based reviews of the major trials together with recommendations for optimum management, and now includes new grading and recommendation methodology. This is a unique book in the field of cardiology, and the largest evidence based clinical cardiology text.
| ISBN | 1444309765 | | Pages | 1240 | | ISBN13 | 9781444309768
(What's this?) | | Weight (grammes) | 3624 | | Publisher | John Wiley and Sons Ltd | | Published in | Chicester | | Imprint | Wiley-Blackwell (an imprint of John Wiley & Sons Ltd) | | Series title | Evidence-Based Medicine | | Format | Audio-Visual / Multimedia Item | | Height (mm) | 283 | | Publication date | 21 May 2010 | | Width (mm) | 224 | | DEWEY | 616.1 | | Spine width (mm) | 58 | | DEWEY edition | DC22 | | Academic level | Professional / Scholarly |
|
|
|
Part I: General concepts and critical appraisal. 1 What is evidence-based cardiology? - PJ Devereaux. 2 A critical appraisal of the cardiovascular history and physical examination - Ernest Fallen. 3 Obtaining incremental information from diagnostic tests - Raymond J Gibbons. 4 Clinical trials and meta-analysis - Colin Baigent, Jonathan Emberson, S Yusuf. 5 Understanding concepts related to health economics - Mark Hlatky. 6 Perioperative Cardiovascular Risk - PJ Devereaux. 7 Implementing evidence based cardiology - Brahmajee Nallamothu, Thomas Tsai. 8 CV Disease and occupational health issues - Michael Joy. PART II Prevention of cardiovascular diseases. 9 Global perspective on cardiovascular disease - K Srinath Reddy. 10 Tobacco: global burden and community solutions - Prabhat Jha. 11 Tobacco and cardiovascular disease: achieving smoking cessation in individuals - Andrew Pipe. 12 Lipids and cardiovascular disease - Malcolm Law. 13 Use of lipid lowering agents in the prevention of cardiovascular disease - Jeffrey L Probstfield, Alan Failor. 14 Blood pressure and cardiovascular disease - Curt Furberg, Bruce M. Psaty, Elsayed Soliman. 15 Glucose abnormalities and cardiovascular disease: "dysglycemia" as an emerging cardiovascular risk factor - Hertzel C Gerstein. 16 Physical activity and exercise in cardiovascular disease prevention and rehabilitation - Ray Squires. 17 Psychosocial factors - Annika Rosengren. 18 Social influences / Social Determinants of Heart Disease - Martin McKee, Clara Chow. 19 Emerging approaches in cardiovascular prevention - Eva M Lonn, Salim Yusuf. 20 Obesity - Arya M Sharma, Raj Padwal. 21 Ethnicity and cardiovascular disease - Sonia S Anand, Clara Chow. 22 The fetal origins of coronary heart disease - Stephanie Atkinson, Katherine Morrison, Koon Teo. 23 Molecular genetics of cardiovascular disorders - atherosclerosis, Bernard Keavney. 24 Molecular genetics of cardiomyopathies and other disorders - Robert Roberts, Ali Marian. 25 Diet and the Global Burden - Srinath Reddy. 26 Integrating approaches to prevention of cardiovascular disease - David Wood. PART IIIa Stable coronary artery disease. 27 Medical management of stable coronary artery disease - William Boden. 28 Percutaneous Intervention - Dave Wood, Chris Buller, Bernard Gersh, Salim Yusuf. 29 Surgical Coronary Artery Revascularization - Thorald Sundt, Bernard Gersh, Salim Yusuf, Morgan Brown. 30 Comparisons of PCI and CABG - Arashk Motiei, Charanjit S. Rihal. PART IIIb Acute Coronary Syndromes. 31 Unstable Angina and Non-ST-segment MI - Pierre Theroux, John Cairns. 32 Early Management of ST-segment-elevation MI - Paul Armstrong, Rob Welsh. 33 Reperfusion therapies for STEMI - J. Brent Muhlestein. 34 Antithrombotic therapies for patients with STEMI - Keith Fox, Andrew Lucking. 35 Complications of STEMI - Peter L Thompson. 36 An integrated approach to the management of patients after the early phase of STEMI - Pedro L Sanchez, Fernando Aviles. PART IIIc Arrhythmias. 37 Atrial fibrillation: rate versus rhythm? - Albert Waldo. 38 Atrial fibrillation: Upstream therapies - Antonios Kourliouros, Irina Savelieva, Marjan Jahangiri, John Camm. 39 Atrial fibrillation: antithrombotic therapy - John A Cairns, Stuart Connolly. 40 Atrial fibrillation: ablation therapy - Andrea Natale, CK Ching. 41 Supraventricular tachycardia: drugs v ablation - Gerald Naccarelli, Erica D. Penny-Peterson. 42 Prevention and treatment of life-threatening ventricular arrhythmia and sudden death - Carlos Morillo. 43 Pacemaker Therapy, including Bi-ventricular Pacing - William Toff, John Camm. 44 Syncope - David Benditt, Fei Lu, Scott Sakaguchi. 45 Cardiopulmonary resuscitation - Michael Colquhoun. 46 New and Old antiarrhythmic Drugs - John Camm, Irina Savelieva. 47 Arrhythmias due to monogenic disorders - Dan Roden, P. Kannankeril, Dawood Darbar. 48 Arrhythmiagenic right ventricular cardiomyopathy (ARVC) - Deirdre Ward, Perry M Elliott. PART IIId Specific cardiovascular disorders: Lef
"Edited by a cadre of highly respected clinical researchers and academicians, the third edition will be a welcome addition to the shelves of cardiologists or primary care physicians with an interest in the dynamic field of cardiology." (JAMA, August 11, 2010) "The text is recommended as a reference text for cardiac centres, cardiologists, cardiac nurse specialists and academic and research institutions." (Nursing Standard, April 2010) "The is a useful addition to the field of cardiology that expands on current comprehensive books ... .The authors have succeeded in creating a multidimensional reference that fulfills their objectives, explaining the how and why of specific interventions." (Doody's, April 2010)
Be the first to write a
customer review
Enlarge
